{
  "docId": "019de076-5923-773b-8485-b914b8e85d5b",
  "docSlug": "aa767e092bc23262b7b522a6b0c001e5",
  "documentTitle": "MindMed | Results Presentation Deck | 20 slides",
  "authorId": "mindmed",
  "authorName": "MindMed",
  "documentKindSlug": "conference-presentation",
  "documentKindLabel": "Conference presentation",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-11-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 16,
  "pageCount": 20,
  "prevPage": 15,
  "nextPage": 17,
  "slideType": "market_sizing",
  "function": "size_opportunity",
  "density": "overcrowded",
  "nDataPoints": 4,
  "notes": "The slide uses a map to show geographic distribution and a stacked bar chart to show sales growth.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de076-5923-773b-8485-b914b8e85d5b/16",
  "deckHref": "/decks/019de076-5923-773b-8485-b914b8e85d5b",
  "deckJsonHref": "/decks/019de076-5923-773b-8485-b914b8e85d5b.json",
  "deckAnchorHref": "/decks/019de076-5923-773b-8485-b914b8e85d5b#slide-16",
  "components": [
    {
      "bbox": {
        "h": 0.35,
        "w": 0.35,
        "x": 0.6,
        "y": 0.55
      },
      "kind": "chart",
      "text": "Reported Spravato Sales",
      "attrs": null,
      "subkind": "bar-stacked",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "bb68ee62-bdf9-4199-a55f-8cd262402c82",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.3,
        "w": 0.35,
        "x": 0.6,
        "y": 0.18
      },
      "kind": "image",
      "text": "Geographic Distribution of Spravato Treatment Centers",
      "attrs": null,
      "subkind": "map",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b560dc43-930c-4f62-8810-bd9141ef61e8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.5,
        "x": 0.03,
        "y": 0.21
      },
      "kind": "list",
      "text": "Monitored Delivery Paradigm Established for Spravato: 8 intranasal 2-hr treatments over a 4-week period (16 hours) with 4 additional 2-hr treatments over 4 weeks (8 hours); translating into at least 24 hours in treatment sessions over the first 8 weeks of treatment alone; Once a week or every 2 weeks thereafter on an individualized basis",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "14a1907d-f3dc-4efc-847d-82f333c67682",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.25,
        "w": 0.5,
        "x": 0.03,
        "y": 0.52
      },
      "kind": "list",
      "text": "Attractive Commercial Opportunity: Over 3,000 treatment centers nationwide; Certified clinicians and physicians; Acceptance by major insurers (United, Cigna, Blue Cross/Blue Shield, etc.); Reported 9M sales of $483m, up 89% compared to the first nine months of 2022",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b7f55279-1ebf-40ee-8fc5-b84e3fcec1a8",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.5,
        "x": 0.16,
        "y": 0.92
      },
      "kind": "source-note",
      "text": "1. Spravato FDA Prescribing Information; 2. Johnson & Johnson; Spravato website. Compiled by company; 3. Company Report Johnson & Johnson; July 20, 2023 Financial Results for 9 months ending September 30, 2023 and September 30, 2022",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cda3dd51-196d-4546-87bd-52ce17be5a89",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.06,
        "w": 0.85,
        "x": 0.03,
        "y": 0.04
      },
      "kind": "title",
      "text": "Potential to Leverage Existing Monitored Delivery Infrastructure",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "b73b15d8-acaf-4eb7-bdbf-059f6dc2f3f6",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.6,
        "x": 0.15,
        "y": 0.11
      },
      "kind": "title",
      "text": "Spravato® (esketamine) for the treatment of Major Depressive Disorder (MDD)",
      "attrs": null,
      "subkind": "subtitle",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "55797bbb-8a25-417e-b00c-34beda30eaa2",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 19,
      "from": 15,
      "beatId": "7eed3be3-4cb2-423a-8635-c5a0198e60ee",
      "arcName": "Problem-Agitate-Solution",
      "arcSlug": "problem-agitate-solution",
      "beatName": "Impact & Next Steps",
      "beatSlug": "consultants-gambit-impact-next-steps",
      "evidence": "Slides 15-19 discuss the potential impact, trial design milestones, and financial results.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": "Resolution",
      "parentBeatSlug": "resolution"
    }
  ],
  "loops": [],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}